United Therapeutics Corporation to Present at TD Cowen Health Care Conference
Michael Benkowitz to Provide Company Overview and Update on March 2, 2026 Why do healthcare conferences matter in the biotech industry? United Therapeutics Corporation a pioneering biotechnology company based in…
Pelage Pharmaceuticals Strengthens Leadership and Board with Strategic Appointments
Pelage Pharmaceuticals Appoints New Board Member and Promotes Key Executives In the competitive landscape of regenerative medicine, where innovative solutions for hair loss are increasingly in demand, Pelage Pharmaceuticals is…
Rocket Pharmaceuticals Advances Rare Disease Treatments With Key Conference Appearances
Rocket Pharmaceuticals to Present at Major Healthcare Conferences in Boston and Miami In the rapidly evolving landscape of genetic therapies, where precision and innovation are paramount, Rocket Pharmaceuticals, Inc. is…
SylamoreBio Partners with Daiichi Sankyo to Advance CNS Therapeutics
Biotech Pioneer SylamoreBio Collaborates with Daiichi Sankyo to Tackle CNS Delivery Challenges How can biotech companies overcome the formidable barriers to delivering therapies to the central nervous system (CNS)? SylamoreBio,…
Blackstone Life Sciences Advances AML Treatment With Bleximenib Funding
BXLS and Johnson & Johnson Collaborate to Fund Bleximenib Clinical Trials for AML Why is the development of new treatments for acute myeloid leukemia (AML) so critical? Despite being the…
Bristol Myers Squibb Advances Alpha-Thalassemia Treatment With Reblozyl
Positive Top-Line Results for Reblozyl in Alpha-Thalassemia Study Is the treatment landscape for alpha-thalassemia about to change? Bristol Myers Squibb has announced positive top-line results from an ongoing, ex-US, Phase…
Merck Reorganizes Human Health Business to Drive Commercial Success
Merck Evolves Structure to Enhance Commercial Execution and Portfolio Growth In an industry where the pace of innovation and market dynamics are constantly evolving, how can pharmaceutical companies ensure they…
Gilead Sciences Acquires Arcellx for $7.8 Billion to Advance Cancer Immunotherapies
Gilead Sciences Seals $7.8 Billion Deal for Arcellx to Boost CAR T-Cell Therapy In the rapidly evolving landscape of cancer immunotherapies, where breakthroughs are crucial for patient outcomes, Gilead Sciences,…
AOP Health Advances Rare Disease Care With Collaborative Data and Patient Engagement
AOP Health Emphasizes Collaboration and Patient-Centered Information on Rare Disease Day 2026 Why is the diagnosis and treatment of rare diseases so challenging? AOP Health, a global enterprise group with…
Savara Reports FDA Filing of BLA for MOLBREEVI in Autoimmune Pulmonary Alveolar Proteinosis
Savara Announces the U.S. Food and Drug Administration (FDA) Filed the MOLBREEVI* Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) Savara Inc. a clinical-stage biopharmaceutical company focused…
Science Corp. Partners with Neurosoft Bioelectronics to Advance Next-Generation BCI Ecosystem
Science Corp. and Neurosoft Bioelectronics Announce Novel BCI Ecosystem Partnership Science Corporation, the pioneering full-stack neural engineering company focused on restoring and extending life, and Neurosoft Bioelectronics, a neural data company…
Dr. Reddy’s Secures FDA Review of Biologics License Application for Abatacept Biosimilar
Dr. Reddy’s Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept Dr. Reddy’s Laboratories Ltd. along with its subsidiaries together referred to as “Dr.…